Cargando…

Antimicrobial Drug–Resistant Shiga Toxin–Producing Escherichia coli Infections, Michigan, USA

High frequencies of antimicrobial drug resistance were observed in O157 and non-O157 Shiga toxin–producing E. coli strains recovered from patients in Michigan during 2010–2014. Resistance was more common in non-O157 strains and independently associated with hospitalization, indicating that resistanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Sanjana, Mosci, Rebekah E., Anderson, Chase M., Snyder, Brian A., Collins, James, Rudrik, James T., Manning, Shannon D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572870/
https://www.ncbi.nlm.nih.gov/pubmed/28820370
http://dx.doi.org/10.3201/eid2309.170523
_version_ 1783259578249510912
author Mukherjee, Sanjana
Mosci, Rebekah E.
Anderson, Chase M.
Snyder, Brian A.
Collins, James
Rudrik, James T.
Manning, Shannon D.
author_facet Mukherjee, Sanjana
Mosci, Rebekah E.
Anderson, Chase M.
Snyder, Brian A.
Collins, James
Rudrik, James T.
Manning, Shannon D.
author_sort Mukherjee, Sanjana
collection PubMed
description High frequencies of antimicrobial drug resistance were observed in O157 and non-O157 Shiga toxin–producing E. coli strains recovered from patients in Michigan during 2010–2014. Resistance was more common in non-O157 strains and independently associated with hospitalization, indicating that resistance could contribute to more severe disease outcomes.
format Online
Article
Text
id pubmed-5572870
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-55728702017-09-02 Antimicrobial Drug–Resistant Shiga Toxin–Producing Escherichia coli Infections, Michigan, USA Mukherjee, Sanjana Mosci, Rebekah E. Anderson, Chase M. Snyder, Brian A. Collins, James Rudrik, James T. Manning, Shannon D. Emerg Infect Dis Research Letter High frequencies of antimicrobial drug resistance were observed in O157 and non-O157 Shiga toxin–producing E. coli strains recovered from patients in Michigan during 2010–2014. Resistance was more common in non-O157 strains and independently associated with hospitalization, indicating that resistance could contribute to more severe disease outcomes. Centers for Disease Control and Prevention 2017-09 /pmc/articles/PMC5572870/ /pubmed/28820370 http://dx.doi.org/10.3201/eid2309.170523 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Mukherjee, Sanjana
Mosci, Rebekah E.
Anderson, Chase M.
Snyder, Brian A.
Collins, James
Rudrik, James T.
Manning, Shannon D.
Antimicrobial Drug–Resistant Shiga Toxin–Producing Escherichia coli Infections, Michigan, USA
title Antimicrobial Drug–Resistant Shiga Toxin–Producing Escherichia coli Infections, Michigan, USA
title_full Antimicrobial Drug–Resistant Shiga Toxin–Producing Escherichia coli Infections, Michigan, USA
title_fullStr Antimicrobial Drug–Resistant Shiga Toxin–Producing Escherichia coli Infections, Michigan, USA
title_full_unstemmed Antimicrobial Drug–Resistant Shiga Toxin–Producing Escherichia coli Infections, Michigan, USA
title_short Antimicrobial Drug–Resistant Shiga Toxin–Producing Escherichia coli Infections, Michigan, USA
title_sort antimicrobial drug–resistant shiga toxin–producing escherichia coli infections, michigan, usa
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572870/
https://www.ncbi.nlm.nih.gov/pubmed/28820370
http://dx.doi.org/10.3201/eid2309.170523
work_keys_str_mv AT mukherjeesanjana antimicrobialdrugresistantshigatoxinproducingescherichiacoliinfectionsmichiganusa
AT moscirebekahe antimicrobialdrugresistantshigatoxinproducingescherichiacoliinfectionsmichiganusa
AT andersonchasem antimicrobialdrugresistantshigatoxinproducingescherichiacoliinfectionsmichiganusa
AT snyderbriana antimicrobialdrugresistantshigatoxinproducingescherichiacoliinfectionsmichiganusa
AT collinsjames antimicrobialdrugresistantshigatoxinproducingescherichiacoliinfectionsmichiganusa
AT rudrikjamest antimicrobialdrugresistantshigatoxinproducingescherichiacoliinfectionsmichiganusa
AT manningshannond antimicrobialdrugresistantshigatoxinproducingescherichiacoliinfectionsmichiganusa